Beyond approval: a mechanism-based review of novel anti-tumour agents in cervical cancer and when to use them.

Yang C, Song X, Sun H, Chen M, Zhu X, Chen X

Open source

DOI
10.3389/fimmu.2026.1948148
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1948148,
  title = {Beyond approval: a mechanism-based review of novel anti-tumour agents in cervical cancer and when to use them.},
  author = {Yang C and Song X and Sun H and Chen M and Zhu X and Chen X},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1948148},
  url = {https://doi.org/10.3389/fimmu.2026.1948148}
}

RIS

TY  - JOUR
TI  - Beyond approval: a mechanism-based review of novel anti-tumour agents in cervical cancer and when to use them.
AU  - Yang C
AU  - Song X
AU  - Sun H
AU  - Chen M
AU  - Zhu X
AU  - Chen X
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1948148
UR  - https://doi.org/10.3389/fimmu.2026.1948148
ER  - 

APA

C, Y., X, S., H, S., M, C., X, Z., & X, C. (2026). Beyond approval: a mechanism-based review of novel anti-tumour agents in cervical cancer and when to use them.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1948148

Source records